Julud Yehya

• Automated Chemistry & Urinalysis Departments
• Operated, calibrated, and maintained high-throughput automated chemistry analyzers to ensure rapid turnaround times for critical medical testing panels.
• Executed stringent daily quality control (QC) protocols and validation sequences, accurately identifying shifts, trends, or instrument errors to perform troubleshooting before releasing results.
• Evaluated quantitative and qualitative urinalysis via physical, chemical, and microscopic examination, meticulously identifying cellular components, casts, and crystals.
• Prioritized and expedited STAT critical alerts by immediately routing abnormal laboratory values to attending physicians and nursing units.
• Hematology & Coagulation Departments
• Conducted precise Complete Blood Count (CBC) evaluations and executed manual differentials to analyze leukocyte, erythrocyte, and platelet distributions.
• Evaluated peripheral blood smears under high-power microscopy to assess cell morphology, detecting pathological variants such as blasts, abnormal inclusions, and sickle variants.
• Performed and interpreted Erythrocyte Sedimentation Rate (ESR) diagnostic measurements to monitor systemic inflammatory processes.
• Immunohematology (Blood Bank Department)
• Performed meticulous forward/reverse ABO typing, Rh factor grouping, and comprehensive unexpected antibody screenings to ensure absolute transfusion compatibility.
• Executed crossmatching procedures and complex compatibility profiles for massive transfusion protocols and emergency blood releases.
• Observed, detailed, and documented standardized transfusion reaction workups, ensuring complete alignment with institutional policies and FDA guidelines.
• NYC PUBLIC HEALTH LABORATORY (PHL) New York, NY
• Microbiology Clinical Rotation Trainee 2025
• Microbiology & Public Health Surveillance Department
• Assisted in the accessioning, inoculating, and clinical processing of highly diverse infectious disease and epidemiologically significant public health specimens.
• Executed specialized microbial culture setups, isolation streaking techniques, and environmental incubation conditions tailored for fastidious pathogenic organisms.
• Identified pathogenic microorganisms utilizing morphological characteristics, differential staining methods, automated identification platforms, and specialized biochemical matrices.
• Enforced uncompromising adherence to Biosafety Level 2/3 (BSL-2/BSL-3) containment mandates, chemical hygiene plans, and institutional infection control protocols.
• Gained critical professional exposure to citywide disease surveillance frameworks, epidemiological tracing reports, and emerging public health threat responses.

Graduated: 2026

International